Description
ADB-FUBINACA
ADB-FUBINACA is a designer drug identified in synthetic cannabis blends in Japan in 2013.The (S) enantiomer of ADB-FUBINACA is claimed in Pfizer patent WO 2009/106982 and has been reported to be a potent agonist of the CB1 receptor and CB2 receptor with an EC50 value of 1.2 nM and 3.5 nM respectively
ADB-FUBINACA
It’s new cannabinoid
IUPAC name: N-(1-Amino-3,3-dimethyl-1-oxobutan-2-yl)-1-(4-fluorobenzyl)-1H-indazole-3-carboxamide
Formula: C21H23FN4O2
Purity: 99,7% min
Appearance: white powder
The physiological and toxicological properties of this compound are not known. This product is intended for forensic and research applications.
Ponce –
I was afraid about buying online, but this is a great site, really serious, they sent the package and it took some time to arrive at home, but it was because of postal office delivery time. The product is great quality 100% recommend it